We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Host sex disparity and viral genotype dependence of the glycosylation level of small Hepatitis B surface protein in patients with HBeAg-positive chronic Hepatitis B

    Background

    Hepatitis B surface antigen (HBsAg) consists of six components of large/middle/small HBs proteins (L/M/SHBs) with non-glycosylated (ng)- or...

    Guomin Ou, Chengyu Zhao, ... Tong Li in Virology Journal
    Article Open access 19 July 2023
  2. Path to Cure Hepatitis B: How Far Are We?

    Hepatitis B infection is caused by the hepatitis B virus (HBV), which damages the liver and can lead to chronic liver diseases such as cirrhosis and...
    Karima Abounouh, Ahd Ouladlahsen, ... Sayeh Ezzikouri in Advances in Antiviral Research
    Chapter 2024
  3. Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy

    Background

    Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor approved for the treatment for several mature B-cell malignancies. Reactivation of...

    Lok-Ka Lam, Thomas Sau Yan Chan, ... Man-Fung Yuen in Virology Journal
    Article Open access 01 August 2023
  4. Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma

    Background

    Epidemiological research and systematic meta-analyses indicate a higher risk of B-cell lymphomas in patients with chronic hepatitis C virus...

    Leihua Fu, Jieni Yu, ... Jing Jin in Infectious Agents and Cancer
    Article Open access 23 April 2024
  5. The Influence of ESR2 Gene Polymorphisms on Susceptibility to Hepatitis B Virus-Related Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma

    Hepatocellular carcinoma (HCC) represents an estrogen-dependent tumor. The action of estrogen is regulated via estrogen receptor (ER). Polymorphisms...

    Zeng Jie, Jiang Hongkun, ... Lu Yu in Biochemical Genetics
    Article 21 January 2024
  6. Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B

    Failure to neutralize HBsAg and subsequent escape from the host immune system may be caused by HBsAg mutations, particularly in the "a" determinant,...

    Malihe Naderi, Seyed Masoud Hosseini, ... Abdolvahab Moradi in Virus Genes
    Article 12 June 2023
  7. SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure

    Background

    Glucocorticoids could greatly improve the prognosis of patients with acute-on-chronic hepatitis B liver failure (ACHBLF). Suppressor of...

    Feng Li, Ying Zhang, ... Kai Wang in Clinical Epigenetics
    Article Open access 06 May 2023
  8. Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4

    Purpose

    To study the correlations of genetic variants of telbivudine phosphorylase kinases and telbivudine plasma concentration with creatine kinase...

    Tianye He, Bicui Chen, ... Jianfei Long in European Journal of Clinical Pharmacology
    Article 19 March 2024
  9. Causal associations between chronic hepatitis B and COVID-19 in East Asian populations

    Background

    The relationship between chronic hepatitis B (CHB) and Coronavirus disease 2019 (COVID-19) has been inconsistent in traditional...

    Zhenguo Liu, Linnan Song, ... Yongyin Li in Virology Journal
    Article Open access 01 June 2023
  10. HCC prediction models in chronic hepatitis B patients receiving entecavir or tenofovir: a systematic review and meta-analysis

    Background

    Our study aimed to compare the predictive performance of different hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B...

    Xiaolan Xu, Lushun Jiang, ... Bing Ruan in Virology Journal
    Article Open access 15 August 2023
  11. Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways

    Background

    Immunotargets including checkpoint inhibitors and toll-like receptor 8 agonists have recently gained attention for the recovery of...

    Arshi Khanam, Alip Ghosh, ... Shyam Kottilil in Journal of Translational Medicine
    Article Open access 21 April 2023
  12. Nanoscale Vaccines for the Prevention of Hepatitis B Virus Infection

    Hepatitis B is a global life-threatening viral infection associated with a high risk of death resulting from chronic liver cirrhosis and liver...
    Poornima Ramburrun, Mershen Govender, Yahya E. Choonara in Nanomedicines for the Prevention and Treatment of Infectious Diseases
    Chapter 2023
  13. Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction

    Chronic hepatitis B (CHB) infection remains a serious public health problem worldwide; however, the relationship between cholesterol levels and CHB...

    Huajun Zhao, Yating Yu, ... Jian Zhang in Cellular & Molecular Immunology
    Article 11 November 2022
  14. Hypermethylation of the glutathione peroxidase 4 gene promoter is associated with the occurrence of immune tolerance phase in chronic hepatitis B

    Background

    Hepatitis B virus (HBV) infection is a public health problem that seriously threatens human health. This study aimed to investigate the...

    Xing Su, Zhaohui Wang, ... Kai Wang in Virology Journal
    Article Open access 21 March 2024
  15. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase

    Background

    The association of hepatitis B virus (HBV) DNA levels and liver fibrosis in chronic hepatitis B (CHB) patients with immune-tolerant phase...

    Jian Wang, Li Zhu, ... Rui Huang in Virology Journal
    Article Open access 04 June 2024
  16. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B

    Background

    Serum hepatitis B virus (HBV) RNA is a surrogate biomarker for intrahepatic covalently closed circular DNA (cccDNA) transcriptional...

    Andreas Laras, Margarita Papatheodoridi, ... Emilia Hadziyannis in Virology Journal
    Article Open access 29 January 2022
  17. Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay

    Background

    The clinical routine test of HBV-specific T cell reactivity is still limited due to the high polymorphisms of human leukocyte antigens...

    Yandan Wu, Xiaotao Liu, ... Chuanlai Shen in Journal of Translational Medicine
    Article Open access 11 March 2024
  18. Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study

    Background

    The co-occurrence of chronic hepatitis B (CHB) and metabolic dysfunction-associated fatty liver disease (MAFLD) has drawn considerable...

    Sitong Yi, Guanghui Ren, ... Qingwei Cong in Virology Journal
    Article Open access 19 January 2024
  19. A noninvasive model discriminating significant histological changes in treatment-naive chronic hepatitis B patients with normal ALT

    Background

    Traditionally part of chronic hepatitis B (CHB) patients with normal alanine aminotransferase (ALT) are recommended to antiviral therapy...

    Jiaming Teng, Yanan Du, ... Wei Cai in Virology Journal
    Article Open access 11 January 2023
  20. Hepatitis Viruses

    Hepatitis is a clinical syndrome caused by many pathogens, including viruses. Viral hepatitis denotes a primary infection caused by a heterologous...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
Did you find what you were looking for? Share feedback.